美好医疗 - Financials

美好医疗 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018
+Revenue	1.6B	1.3B	1.4B	1.1B	888.0M	742.0M	582.0M
Revenue Growth %	19.1%	-5.4%	24.5%	28.0%	19.7%	27.5%	--
Total Revenue	1.6B	1.3B	1.4B	1.1B	888.0M	742.0M	582.0M
Cost Of Revenue	923.0M	787.0M	806.0M	627.0M	444.0M	380.0M	322.0M
+Gross Profit	671.0M	551.0M	609.0M	510.0M	444.0M	362.0M	260.0M
Gross Margin %	42.1%	41.2%	43.0%	44.9%	50.0%	48.8%	44.7%
Total Operating Cost	1.2B	1.0B	969.0M	798.0M	609.0M	495.0M	435.0M
Selling Expenses	45.1M	31.8M	26.1M	26.1M	23.8M	20.3M	24.1M
Admin Expenses	108.0M	101.0M	84.0M	50.6M	52.7M	39.5M	51.6M
Rd Expenses	141.0M	120.0M	87.7M	63.9M	48.6M	40.8M	32.7M
Finance Expenses	-48.9M	-52.2M	-49.2M	8.4M	30.6M	-5.3M	-7.5M
+Operating Income	410.0M	352.0M	457.0M	348.0M	294.0M	265.0M	149.0M
Operating Margin %	25.7%	26.3%	32.3%	30.6%	33.1%	35.7%	25.6%
Non Operating Income	5,600	22,300	22,300	1,500	31,200	74,200	671,600
Non Operating Expenses	235,900	316,500	107,800	184,800	398,100	47,000	141,800
Investment Income	10.1M	15.7M	525,200	3.5M	7.6M	3.8M	750,900
Fair Value Change Income	837,700	83,800	329,500	190,900	--	--	--
Asset Disposal Income	-279,900	-85,000	150,300	87,300	132,100	-88,000	-326,000
Asset Impairment Loss	13.8M	7.4M	3.0M	10.2M	434,100	11.4M	6.9M
Other Income	10.7M	14.7M	9.6M	5.0M	7.3M	14.1M	834,300
Income Before Tax	410.0M	351.0M	457.0M	348.0M	294.0M	265.0M	149.0M
Income Tax	46.5M	38.1M	54.6M	38.1M	35.9M	33.0M	18.1M
+Net Income	364.0M	313.0M	402.0M	310.0M	258.0M	232.0M	131.0M
Net Margin %	22.8%	23.4%	28.4%	27.3%	29.1%	31.3%	22.5%
Net Income Attributable	364.0M	313.0M	402.0M	310.0M	258.0M	232.0M	131.0M
Eps Basic	0.90	0.77	1.08	0.86	0.71	0.72	0.41
Eps Diluted	0.90	0.77	1.08	0.86	0.71	0.72	0.41

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018
Cash And Equivalents	1.3B	1.7B	1.2B	420.0M	533.0M	494.0M	185.0M
Trading Financial Assets	492.0M	15.8M	526.0M	13.9M	2.5M	85.0M	--
Accounts Receivable	345.0M	213.0M	203.0M	217.0M	145.0M	115.0M	94.8M
Notes Receivable	7.4M	14.6M	1.4M	1.3M	1.6M	--	201,600
Notes And Accounts Receivable	352.0M	228.0M	204.0M	218.0M	147.0M	115.0M	95.0M
Prepayments	12.7M	19.7M	19.8M	28.1M	8.8M	4.2M	3.5M
Inventory	330.0M	375.0M	433.0M	314.0M	137.0M	120.0M	97.3M
Total Current Assets	2.5B	2.4B	2.4B	1.1B	851.0M	837.0M	412.0M
Fixed Assets	--	867.0M	817.0M	270.0M	191.0M	120.0M	115.0M
Fixed Assets Total	871.0M	867.0M	817.0M	271.0M	191.0M	120.0M	115.0M
Construction In Progress	--	162.0M	39.6M	457.0M	268.0M	113.0M	7.2M
Construction In Progress Total	463.0M	162.0M	39.6M	457.0M	268.0M	113.0M	7.2M
Intangible Assets	81.5M	79.7M	81.4M	82.4M	85.8M	50.8M	50.8M
Long Term Deferred Expenses	903,800	3.9M	5.4M	143,400	1.6M	2.7M	9.2M
Total Non Current Assets	1.5B	1.2B	963.0M	851.0M	550.0M	299.0M	186.0M
Total Assets	3.9B	3.5B	3.4B	1.9B	1.4B	1.1B	597.0M
Short Term Borrowings	--	--	--	30.0M	--	--	--
Accounts Payable	212.0M	111.0M	160.0M	186.0M	150.0M	84.1M	45.2M
Advance Receipts	--	--	--	--	--	18.2M	10.9M
Contract Liabilities	78.7M	67.5M	62.0M	55.1M	21.0M	--	--
Total Current Liabilities	372.0M	272.0M	307.0M	375.0M	217.0M	131.0M	75.3M
Long Term Borrowings	--	--	--	82.1M	--	24.8M	--
Total Non Current Liabilities	69.6M	68.7M	59.8M	134.0M	17.4M	39.6M	22.0M
Total Liabilities	442.0M	341.0M	367.0M	509.0M	234.0M	170.0M	97.3M
Paid In Capital	407.0M	407.0M	407.0M	362.0M	362.0M	362.0M	104.0M
Capital Reserve	1.6B	1.6B	1.6B	417.0M	417.0M	409.0M	276.0M
Surplus Reserve	104.0M	94.1M	78.5M	49.6M	25.8M	6.2M	17.7M
Retained Earnings	1.4B	1.1B	949.0M	575.0M	362.0M	181.0M	101.0M
Equity Attributable	3.5B	3.2B	3.0B	1.4B	1.2B	965.0M	500.0M
Total Equity	3.5B	3.2B	3.0B	1.4B	1.2B	965.0M	500.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018
Cash From Sales	1.5B	1.3B	1.5B	1.1B	866.0M	737.0M	578.0M
Tax Refunds Received	27.1M	41.9M	89.8M	23.0M	19.1M	20.1M	37.3M
Total Operating Cash Inflow	1.6B	1.4B	1.6B	1.2B	905.0M	782.0M	620.0M
Cash Paid For Goods	645.0M	638.0M	833.0M	674.0M	347.0M	323.0M	278.0M
Cash Paid To Employees	388.0M	344.0M	294.0M	201.0M	165.0M	134.0M	117.0M
Taxes Paid	63.0M	48.0M	67.7M	40.7M	52.4M	54.2M	22.2M
Total Operating Cash Outflow	1.1B	1.1B	1.2B	957.0M	603.0M	559.0M	452.0M
Operating Cash Flow	448.0M	351.0M	381.0M	196.0M	303.0M	223.0M	168.0M
Total Investing Cash Inflow	4.8B	3.7B	33.6M	1.2B	3.3B	1.3B	406.0M
Total Investing Cash Outflow	5.5B	3.8B	910.0M	1.5B	3.1B	1.8B	553.0M
Investing Cash Flow	-728.0M	-73.4M	-876.0M	-326.0M	175.0M	-436.0M	-147.0M
Cash From Borrowings	--	--	21.4M	177.0M	--	24.8M	--
Dividends And Interest Paid	64.8M	143.0M	6.2M	73.7M	58.4M	52.5M	20.7M
Debt Repayments	--	--	133.0M	64.7M	24.8M	--	--
Total Financing Cash Inflow	--	--	1.3B	177.0M	--	304.0M	--
Total Financing Cash Outflow	122.0M	153.0M	169.0M	153.0M	83.1M	52.5M	20.7M
Financing Cash Flow	-122.0M	-153.0M	1.1B	24.0M	-83.1M	252.0M	-20.7M
Net Change In Cash	-374.0M	133.0M	647.0M	-118.0M	361.0M	46.2M	9.8M
Ending Cash Balance	818.0M	1.2B	1.1B	412.0M	530.0M	169.0M	123.0M
Capex	363.0M	259.0M	201.0M	316.0M	239.0M	118.0M	63.6M